Oral semaglutide proved nearly as effective as the injectable version for treating obesity, delivering 13.7 percent average weight loss in a 64-week trial.
State lawmakers endorsed competing plans to lower insurance costs, but failed to pass an extension for expiring Affordable Care Act subsidies this year.
After four years of delays, the state commission finally granted dispensary licenses, but advocates called the limited number an "abysmal excuse for access."